{"Symbol": "RMD", "AssetType": "Common Stock", "Name": "ResMed Inc", "Description": "ResMed is a San Diego, California-based medical equipment company. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea (such as CPAP devices and masks), chronic obstructive pulmonary disease (COPD), and other respiratory conditions.", "CIK": "943819", "Exchange": "NYSE", "Currency": "USD", "Country": "USA", "Sector": "LIFE SCIENCES", "Industry": "SURGICAL & MEDICAL INSTRUMENTS & APPARATUS", "Address": "9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA, US", "FiscalYearEnd": "June", "LatestQuarter": "2021-09-30", "MarketCapitalization": "37933261000", "EBITDA": "1073527000", "PERatio": "75.39", "PEGRatio": "3.833", "BookValue": "20.77", "DividendPerShare": "1.62", "DividendYield": "0.0062", "EPS": "3.412", "RevenuePerShareTTM": "23.02", "ProfitMargin": "0.149", "OperatingMarginTTM": "0.287", "ReturnOnAssetsTTM": "0.129", "ReturnOnEquityTTM": "0.175", "RevenueTTM": "3348896000", "GrossProfitTTM": "1889459000", "DilutedEPSTTM": "3.412", "QuarterlyEarningsGrowthYOY": "0.139", "QuarterlyRevenueGrowthYOY": "0.202", "AnalystTargetPrice": "265.83", "TrailingPE": "75.39", "ForwardPE": "43.67", "PriceToSalesRatioTTM": "11.33", "PriceToBookRatio": "12.67", "EVToRevenue": "11.65", "EVToEBITDA": "34.17", "Beta": "0.295", "52WeekHigh": "300.86", "52WeekLow": "178.46", "50DayMovingAverage": "266.17", "200DayMovingAverage": "236.21", "SharesOutstanding": "145723000", "DividendDate": "2021-12-16", "ExDividendDate": "2021-11-09"}